Enanta Pharmaceuticals Inc SEC filings ENTA
Enanta Pharmaceuticals Inc has 835 filings in SEC EDGAR's recent list, going back to Jun 21, 2002. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Feb 20, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 26, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 8, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| POSASR | Filing | Nov 22, 2023 | — |
| NT 10-Q | Filing | Feb 10, 2022 | Dec 31, 2021 |
| DEFR14A | Filing | Jan 28, 2021 | — |
| CT ORDER | Filing | Feb 17, 2016 | — |
| CT ORDER | Filing | Mar 16, 2015 | — |
| CT ORDER | Filing | Jun 28, 2013 | — |
| CT ORDER | Filing | Mar 21, 2013 | — |
| EFFECT | Filing | Mar 20, 2013 | — |
| CERTNAS | Auto-generated paper document | Mar 19, 2013 | — |
| CORRESP | Letter to the SEC | Mar 18, 2013 | — |
| CORRESP | Letter to the SEC | Mar 18, 2013 | — |
| 8-A12B | Form 8-a | Mar 18, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2013 | — |
| CORRESP | Letter to the SEC | Feb 8, 2013 | — |
| CORRESP | Letter to the SEC | Jan 23, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2013 | — |
| CORRESP | Letter to the SEC | Jan 15, 2013 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2012 | — |
| CORRESP | Letter to the SEC | Nov 6, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2012 | — |
| REGDEX | Auto-generated paper document | Jun 21, 2002 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENTA (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1177648
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.